Report Title:
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2018 Published On: January 2018
Category: Life Sciences
Pages: 69
Report Overview: Diabetic Peripheral Neuropathy Pipeline Review, H1 2018 Summary Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy Pipeline Review, H1 2018, provides an overview of the Diabetic Peripheral Neuropathy Metabolic Disorders pipeline landscape. "Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or tingling in the feet pain or discomfort in the feet or legsincluding prickly, sharp pain or burning feet, muscle weakness and loss of muscle tone in the feet and lower legs, loss of balance, dry feet and cracked skin. The predisposing factors include diabetes, smoking and kidney diseases. Treatment includes antidepressants, antiseizure and opioid analgesics." Report Highlights Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Diabetic Peripheral Neuropathy Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy Metabolic Disorders, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Diabetic Peripheral Neuropathy Metabolic Disorders pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 8, 2 and 8 respectively.
24marketreports | International +1 646 781 7170 | www.24marketreports.com